← Directory

Perceptive Advisors

PE / VC · New York · United States

Address
51 Astor Place, 10th floor New York, NY 10003
Email
Website
LinkedIn
Founded
1999
AUM
$9 700 M
Ticket
$10-50 m

Stages

Series BSeries ASeedLate Stage (Series C+)

Investment region

EuropeNorth AmericaAsia

Industries

RoboticsAIMedTechLife SciencesHealthTechBiotechnologyHealthcare ServicesMedical DevicesOtherPharmaceuticals

Profile

Perceptive Advisors is a life sciences-focused investment firm based in New York City, founded in 1999. The firm was established to identify and support promising innovations in the healthcare field. The team consists of individuals with a strong background in both scientific and investment expertise, which enables them to assess and invest in breakthrough healthcare technologies. The firm stands out for its dedication to integrating scientific insight with investment acumen in their approach to funding life sciences advancements. Perceptive Advisors invests primarily in the healthcare sector, with particular interest in biopharmaceuticals and medical technology. Their investment strategy spans both private and public companies, and they consider a variety of capital structures. While specific check sizes are not detailed, the stages range from early to late, covering various phases of company growth. Notable funds include the Perceptive Life Sciences Fund, designed to encompass diverse investments within this field. The firm has an impressive portfolio, which includes companies like Achilles Therapeutics - focused on cancer immunotherapies, AEGEA Medical - working on medical vapor ablation technology, Affimed - developing cancer immunotherapies, Agile Therapeutics - specializing in women's healthcare products, and Athenex - dedicated to cancer therapy development. They are recognized for their role in advancing products with substantial potential for healthcare improvements.

Contacts (2)

NameTitleEmailTéléphoneLinkedIn
Managing Director
Partner, Venture (PXV Fund)

Name, email and phone are partially hidden. Subscribe to see them in full.